A Study to Evaluate the Relative Bioavailability of Two Tablet Formulations Compared to Capsule Formulation and the Effect of Food and Proton Pump Inhibitor on ZN-A-1041 Tablet(s) in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 27, 2025

Primary Completion Date

July 12, 2025

Study Completion Date

July 12, 2025

Conditions

Healthy Participants

Interventions

DRUG

ZN-A-1041

Participants will be administered either a ZN-A-1041 capsule or a tablet orally.

Trial Locations (1)

Fortrea Leeds CRU, Leeds